Search research articles
Contact Us
Filters
Showing results (1111-1120 of 1,161) with videos related to
Page
of 117
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
August 7, 2022
Incorporating progesterone receptor expression into the PREDICT breast prognostic model
Isabelle Grootes, Renske Keeman, Fiona M Blows, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 21, 2023
Concurrent RB1 loss and <i>BRCA</i>-deficiency predicts enhanced immunological response and long-term survival in tubo-ovarian high-grade serous carcinoma
Flurina A M Saner, Kazuaki Takahashi, Timothy Budden, et al.
Scientific Reports
|
October 6, 2021
Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis
Maria Escala-Garcia, Sander Canisius, Renske Keeman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 5, 2024
Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma
Flurina A M Saner, Kazuaki Takahashi, Timothy Budden, et al.
Cancer Causes & Control : CCC
|
April 8, 2016
Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry
Zhiguo Zhao, Wanqing Wen, Kyriaki Michailidou, et al.
Virchows Archiv : an International Journal of Pathology
|
November 16, 2021
MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma
Eun Young Kang, Joshua Millstein, Gordana Popovic, et al.
Human Mutation
|
February 21, 2018
The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity
Mara Colombo, Irene Lòpez-Perolio, Huong D Meeks, et al.
American Journal of Human Genetics
|
September 20, 2016
Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation
Maya Ghoussaini, Juliet D French, Kyriaki Michailidou, et al.
The Journal of Pathology. Clinical Research
|
March 22, 2023
p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study
Martin Köbel, Eun-Young Kang, Ashley Weir, et al.
Research Square
|
November 19, 2025
Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinoma
Dale Garsed, Tibor Zwimpfer, Sian Fereday, et al.
Page
of 117
Search research articles
Search
Showing results (1111-1120 of 1,161) with videos related to
Sort By:
Page
of 117
European Journal of Cancer (Oxford, England : 1990)
|
August 7, 2022
Incorporating progesterone receptor expression into the PREDICT breast prognostic model
Isabelle Grootes, Renske Keeman, Fiona M Blows, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 21, 2023
Concurrent RB1 loss and <i>BRCA</i>-deficiency predicts enhanced immunological response and long-term survival in tubo-ovarian high-grade serous carcinoma
Flurina A M Saner, Kazuaki Takahashi, Timothy Budden, et al.
Scientific Reports
|
October 6, 2021
Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis
Maria Escala-Garcia, Sander Canisius, Renske Keeman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 5, 2024
Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma
Flurina A M Saner, Kazuaki Takahashi, Timothy Budden, et al.
Cancer Causes & Control : CCC
|
April 8, 2016
Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry
Zhiguo Zhao, Wanqing Wen, Kyriaki Michailidou, et al.
Virchows Archiv : an International Journal of Pathology
|
November 16, 2021
MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma
Eun Young Kang, Joshua Millstein, Gordana Popovic, et al.
Human Mutation
|
February 21, 2018
The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity
Mara Colombo, Irene Lòpez-Perolio, Huong D Meeks, et al.
American Journal of Human Genetics
|
September 20, 2016
Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation
Maya Ghoussaini, Juliet D French, Kyriaki Michailidou, et al.
The Journal of Pathology. Clinical Research
|
March 22, 2023
p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study
Martin Köbel, Eun-Young Kang, Ashley Weir, et al.
Research Square
|
November 19, 2025
Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinoma
Dale Garsed, Tibor Zwimpfer, Sian Fereday, et al.
Page
of 117